Dilek Top Karti, Omer Karti, Figen Gokcay, Nese Celebisoy
Journal: Cutaneous and ocular toxicology 2020;38(3):249-252
PMID: 30793994
This study was aimed to investigate the acute effect of caffeine intake on pattern-reversal (PR) visual evoked potential (VEP). This randomized controlled study included 40 participants who were divided into two groups randomly (group 1 [study group, = 20] and group 2 [control group, = 20]). While the study group received coffee beverages made from 6 g pure coffee beans (36 mg of caffeine per gram) containing approximately 216 mg caffeine, the control group was given beverages containing 200 mg lactose without caffeine. PR-VEP test was performed at baseline and 1 h after the beverage intake. The right eyes of both groups were used for the statistical analysis. The median age of group 1 (8 male and 12 female) and group 2 (7 male and 13 female) were 31.0 (range, 21-59) and 36.5 (range, 20-59) years, respectively. No statistically significant difference was found between two groups in terms of age ( = 0.398) and gender ( = 0.744). Before the caffeine intake, median P100 latency and amplitudes were 109.90 ms (range: 99.60-120.60) and 12.45 µV (range: 5.20-19.30), respectively. One hour after caffeine intake, corresponding values were 110.70 ms (range: 99.00-114.60) and 12.45 µV (range: 5.70-20.0). Baseline P100 latency and amplitude values were not significantly different from the values recorded 1 h after caffeine intake ( > 0.05). This study showed that ingesting moderate amounts of caffeine did not affect PR-VEP parameters. Therefore, caffeine restriction does not seem to be required before the PR-VEP test. Further studies are needed to confirm our findings.
Medical:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.